there is no increased risk in comparison to control arms of intracranial bleeding with the addition of a GP IIb/IIIa inhibitor. Few data, however, are available for higher risk patient ...
These drugs include abciximab, eptifibatide and tirofiban. Glycoprotein IIb/IIIa inhibitors very strongly inhibit platelet function by blocking fibrinogen binding to the activated glycoprotein IIb ...
For example, a recent study describes how the antifungal antibiotic aureobasidin A can be an effective inhibitor of the MDR1 P-glycoprotein 18, and this is likely to become a significant addition ...
A recent study published in PLOS Pathogens examined two newly identified nanobodies, Nanosota-EB1 and Nanosota-EB2, as potential inhibitors ... particularly the glycoprotein (GP) of the Ebola ...
INR: International normalized ratio; P-gp: P-glycoprotein; SSRI: Selective serotonin inhibitor. Adapted with permission from [9,21]. Events Rivaroxaban (number per 100 patient years) Warfarin ...
a novel potent and selective inhibitor. The role of glycodelin in cancer cell differentiation and reproductive biology Glycodelin is a lipocalin family glycoprotein expressed mainly in reproductive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results